December 8, 2021
TOKYO (Jiji Press) — Japan’s current account surplus shrank in October as growth of imports outpaced that of exports partly reflecting higher crude oil prices, the Finance Ministry said Wednesday.
The surplus in the current account, the country’s broadest measure of trade and investment flows, dropped 39.4% from a year before to ¥1,180.1 billion, down for the third straight month, the ministry said in a preliminary balance of payments report. The result came against a median forecast of ¥1,308.5 billion in surplus among 18 economic research institutes surveyed by Jiji Press.
In goods trade, Japan’s surplus decreased 82.5% to ¥166.7 billion.
Exports rose 11.7% to ¥7,080 billion, and imports were up 28.3% at ¥6,913.2 billion. While vehicle exports slumped due to production cuts amid semiconductor shortages, imports of crude oil, coal and liquefied natural gas grew sharply. Japan logged ¥575.4 billion in services trade deficit. The surplus on the primary income account expanded 11.5% to ¥1,780.3 billion thanks to increased dividends from resources-related companies overseas that performed well on the back of higher crude oil prices.
Top Articles in Business
-
Nippon Life Insurance’s U.S. Arm Sues OpenAI Over Legal Assistance Provided by ChatGPT
-
Japan, U.S. Name 3 Inaugural Investment Projects; Reached Agreement After Considerable Difficulty
-
Japan’s Major Real Estate Firms Expanding Overseas Businesses to Secure Future Growth, Focusing on Europe, U.S., Asia
-
JR Tokai Breaks Ground on Yamanashi Maglev Station; Will Be Part of Linear Chuo Shinkansen Line from Tokyo to Nagoya
-
Transport Companies See Opportunity in Narita Expansion; Airlines, Railways Prepare to Meet Expected Growth in Demand
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

